HUM — Humana Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Key stats#
Data provided bySource: Twelve DataPrice data
- Price
- $423.22
- YTD price return
- +65.24%
- YTD total return
- +66.82%
- Market cap
- 50.8B
- Enterprise value
- 38.8B
- Shares outstanding
- 120.1M
- 52W low
- $163.11
- 52W high
- $456.50
- From 52W high
- -7.29%
- From 52W low
- +159.47%
- 52W range
- 89%$163–$457
- Beta
- 0.73
Volume
- Rel volume
- 1.52×
- 30D volume
- 1.6M
- 30D $ vol
- 669.1M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- none
- Insider net 1Y
- +$150K
Form 4 transactions by trade date, as filed; latest on file 2026-02-23.
Fundamentals
- Sales (ttm)
- 154.2B
- Sales/share
- $1,283.77
- EPS (ttm)
- $10.29
- FCF (ttm)
- 3.1B
- FCF/share
- $26.14
- Book value/share
- $156.74
- Net margin
- 0.81%
- ROE
- 6.62%
- ROA
- 2.18%
- Debt / equity
- 0.61×
- Current ratio
- 1.65
Growth (CAGR, ttm) · 10Y
- Sales
- +22.04%+14.63%+13.72%+10.89%
- Net income
- -3.49%-25.51%-14.16%+1.11%
- FCF
- +103.01%-14.42%+17.53%-3.56%
- Shares
- -0.14%-0.82%-1.35%-2.14%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -3.78%-24.67%-12.90%+3.36%
- Sales/share
- +22.21%+15.58%+15.28%+13.31%
- FCF/share
- +103.29%-13.71%+19.13%-1.46%
- Book value/share
- +1.78%+4.42%+4.38%+7.55%
- Dividend/share
- +0.00%+1.16%+5.57%+11.80%
- Price
- +77.86%-5.10%-1.24%+8.98%
- Total return
- +80.19%-3.93%-0.24%+9.91%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 41.1×
- P/OI (ttm)
- 21.3×
- Fwd P/E
- 23.8×
- P/S (ttm)
- 0.3×
- P/B (mrq)
- 2.7×
- P/FCF (ttm)
- 16.2×
- EV/EBITDA (fy)
- 12.4×
- EV/Sales (ttm)
- 0.3×
- FCF yield (ttm)
- 6.18%
- Dividend yield (fwd)Div yield
- 0.84%
- Dividend yield (ttm)
- 0.84%
- Dividend/share (fwd)
- $3.54
- Buyback yield (realized, 1y)
- 0.14%
- Shareholder yield (realized, 1y)
- 1.51%
- Buyback yield (cash, ttm)
- 0.30%
- Shareholder yield (cash, ttm)
- 1.14%
Vs own 10Y history
- P/E
- 97th
- P/OI
- 99th
- P/S
- 20th
- P/B
- 27th
- P/FCF
- 59th
Bar = where today’s multiple sits in HUM’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).
Performance · price returntotal return · as of 2026-11-09#
Data provided bySource: Twelve DataFundamentals#
Operating income
5Y CAGR −11.5%10Y CAGR +1.4%YoY −81.3%EPS (diluted)
5Y CAGR −17.2%10Y CAGR +1.5%YoY −17.9%Free cash flow
5Y CAGR −39.6%10Y CAGR +0.8%YoY +142.3%TTM: operating cash flow $3.7B, capex −$592M
Q3 2026: operating cash flow $2.2B, capex −$137M
Shares (diluted)
5Y −9.2%10Y −20.1%YoY +0.9%Dividend per share
5Y CAGR +7.8%10Y CAGR +11.9%YoY +0.0%About Humana#
Data provided bySource: Twelve DataHumana Inc. is a U.S. healthcare company focused on health insurance and healthcare services. Humana provides a broad range of products and services through its Insurance and CenterWell segments, including Medicare Advantage plans, Medicare prescription drug coverage, Medicare supplement products, Medicaid-related offerings, military health administration, and employer-sponsored medical and specialty benefits. Through CenterWell, the company also delivers senior-focused primary care, pharmacy services, home health care, and other coordinated care solutions designed to support members across different stages of treatment. Humana serves individuals, families, employers, government program beneficiaries, and military personnel, with a strong emphasis on government-sponsored healthcare programs and senior care. Headquartered in Louisville, Kentucky, Humana plays a significant role in the U.S. managed care market by combining insurance coverage with integrated care delivery services.
Louisville, KY·67,060 employees·Healthcare Plans·humana.com·As of Oct 28, 2026
Recent filings#
- Nov 98-K · Humana Commences Offers to Purchase for Cash Certain of its Outstanding Debt Securities
- Nov 6Earnings · Earnings release — EPS −$0.70 vs −$1.03 est. (+32.0%); revenue $41.16B (+26% y/y) 5.3%
- Oct 138-K · Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics
- Jul 29Earnings · Earnings release — EPS $7.61 vs $6.22 est. (+22.4%); revenue $40.87B (+26% y/y) 6.0%
- Jul 298-K · Humana Elects Paul Smith and Frederick Crawford to Board of Directors
ETFs holding HUM#
34 of the 193 ETFs ChartRow carries live hold HUM. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).
| Fund | Name | Filed weight |
|---|---|---|
| XLV | Health Care Select Sector SPDR Fund | 0.8% |
| VOE | Vanguard Mid-Cap Value ETF | 0.8% |
| VHT | Vanguard Health Care ETF | 0.6% |
| IWS | iShares Russell Mid-Cap Value ETF | 0.5% |
| VO | Vanguard Mid-Cap ETF | 0.5% |
| IWR | iShares Russell Midcap ETF | 0.3% |
| RSP | Invesco S&P 500 Equal Weight ETF | 0.2% |
| VTV | Vanguard Value ETF | 0.2% |
Related Healthcare#
Data provided bySource: Twelve Data| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +19.73% | +4.28% |
| JNJ | Johnson & Johnson | +7.91% | +2.13% |
| ABBV | AbbVie Inc. | +6.09% | +0.68% |
| MRK | Merck & Co. Inc. | +2.17% | +1.38% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +4.83% | +0.88% |
| NVS | Novartis AG | +13.87% | +0.70% |
| TMO | Thermo Fisher Scientific Inc. | +9.67% | +3.87% |
| AMGN | Amgen Inc. | +12.14% | +1.04% |
